Mechanisms underlying the nociceptive and inflammatory responses induced by trypsin in the mouse paw

被引:35
作者
Paszcuk, Ana Flavia [1 ]
Quintao, Nara L. M. [1 ]
Fernandes, Elizabeth S. [1 ]
Juliano, Luiz [2 ]
Chapman, Kevin [4 ]
Andrade-Gordon, Patricia
Campos, Maria Martha [3 ]
Vergnolle, Nathalie [4 ]
Calixto, Joao B. [1 ]
机构
[1] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Pharmacol, BR-88049900 Florianopolis, SC, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, Sao Paulo, Brazil
[3] Pontificia Univ Catolica Rio Grande do Sul, Sch Dent, Porto Alegre, RS, Brazil
[4] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB, Canada
关键词
trypsin; inflammation; edema; nociception; PAR-2; (Mouse);
D O I
10.1016/j.ejphar.2007.11.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been demonstrated that trypsin is able to evoke the classical signals of inflammation, mainly via the activation of proteinase-activated receptor-2 (PAR-2). This study was designed to evaluate the inflammatory and nociceptive responses caused by trypsin injection in the mouse paw. Trypsin produced a dose- and time-related paw edema, a response that was markedly reduced in PAR-2-deficient mice compared to wild-type mice, particularly at the early time-points after trypsin injection. In addition, trypsin produced an increase in myeloperoxidase (MPO) activity, which was significantly reduced in PAR-2-deficient mice. The injection of trypsin into the mouse paw also elicited a dose- and time-dependent spontaneous nociception, as well as thermal and mechanical hypernociceptive responses, which were consistently decreased in mice with genetic deletion of PAR-2. Pharmacological evaluation revealed that edema formation and spontaneous nociception caused by trypsin injection in the mouse paw are mediated by a complex range of mediators. Both edema and nociception seem to rely on the production of neuropeptides, probably involving C-fibre activation and vanilloid receptor-1 (TRPV1), besides the stimulation of kinin B-2 receptors. Edematogenic response is also likely related to the production of cyclooxygenase (COX) metabolites, whereas the mast cell activation appears to be greatly associated to spontaneous nociception. Altogether, the present results indicate that trypsin-induced edema and nociception in the mouse paw represent multi-mediated responses that are largely, but not exclusively, related to the activation of PAR-2. These pieces of evidence provide new insights on the role of trypsin in pain and inflammation. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:204 / 215
页数:12
相关论文
共 36 条
[1]   Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cε- and A-dependent mechanisms in rats and mice [J].
Amadesi, Silvia ;
Cottrell, Graeme S. ;
Divino, Lorna ;
Chapman, Kevin ;
Grady, Eileen F. ;
Bautista, Francisco ;
Karanjia, Rustum ;
Barajas-Lopez, Carlos ;
Vanner, Stephen ;
Vergnolle, Nathalie ;
Bunnett, Nigel W. .
JOURNAL OF PHYSIOLOGY-LONDON, 2006, 575 (02) :555-571
[2]   Contribution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions [J].
Calixto, JB ;
Kassuya, CAL ;
André, E ;
Ferreira, J .
PHARMACOLOGY & THERAPEUTICS, 2005, 106 (02) :179-208
[3]   Kinin B1 receptors:: key G-protein-coupled receptors and their role in inflammatory and painful processes [J].
Calixto, JB ;
Medeiros, R ;
Fernandes, ES ;
Ferreira, J ;
Cabrini, DA ;
Campos, MM .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (07) :803-818
[4]   Modulation of kinin B1 but not B2 receptors-mediated rat paw edema by IL-1β and TNFα [J].
Campos, MM ;
Souza, GEP ;
Calixto, JB .
PEPTIDES, 1998, 19 (07) :1269-1276
[5]   Caffeic acid derivatives:: In vitro and in vivo anti-inflammatory properties [J].
Da Cunha, FM ;
Duma, D ;
Assreuy, J ;
Buzzi, FC ;
Niero, R ;
Campos, MM ;
Calixto, JB .
FREE RADICAL RESEARCH, 2004, 38 (11) :1241-1253
[6]  
Damiano BP, 1999, THROMB HAEMOSTASIS, V81, P808
[7]  
DUNN BM, 1989, DETERMINATION PROTEA, P57
[8]   Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression [J].
Fernandes, ES ;
Passos, GF ;
Campos, MM ;
de Souza, GEP ;
Fittipaldi, JF ;
Pesquero, JL ;
Teixeira, MM ;
Calixto, JB .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (02) :209-216
[9]   Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice [J].
Ferreira, J ;
da Silva, GL ;
Calixto, JB .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (05) :787-794
[10]   SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor:: Biochemical and pharmacological characterization [J].
Gougat, J ;
Ferrari, B ;
Sarran, L ;
Planchenault, C ;
Poncelet, M ;
Maruani, J ;
Alonso, R ;
Cudennec, A ;
Croci, T ;
Guagnini, F ;
Urban-Szabo, K ;
Martinolle, JP ;
Soubrié, P ;
Finance, O ;
Le Fur, G .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (02) :661-669